scispace - formally typeset
M

Marta Busnelli

Researcher at University of Milan

Publications -  37
Citations -  2471

Marta Busnelli is an academic researcher from University of Milan. The author has contributed to research in topics: Oxytocin receptor & Receptor. The author has an hindex of 20, co-authored 35 publications receiving 2031 citations. Previous affiliations of Marta Busnelli include University of Milano-Bicocca & National Research Council.

Papers
More filters
Journal ArticleDOI

Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism

TL;DR: It is shown that autistic-like symptoms are rescued on administration of AVP and OT to young Oxtr(-/-) adult animals and that intracerebral administration of both OT and AVP lowers aggression and fully reverts social and learning defects by acting on V1a receptors and that seizure susceptibility is antagonized by peripherally administered OT.
Journal ArticleDOI

Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain.

TL;DR: The evolutionarily and ontogenetically determined pathways of OT delivery and OT signaling, which orchestrate activity of the mesolimbic social decision-making network, are discussed.
Journal ArticleDOI

Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice

TL;DR: Chronic intranasal OXT treatment in wild-type C57BL/6J adult mice produced a selective reduction of social behaviors concomitant to a reduction of the OXT receptors throughout the brain, indicating that a prolonged over-stimulation of a ‘healthy’ oxytocinergic brain system results in specific detrimental effects in social behaviors.
Journal ArticleDOI

Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes

TL;DR: Both analogs inhibited cell proliferation, showing that a single Gi subtype-mediated pathway is sufficient to prompt this physiological response and open the way to the development of drugs with peculiar selectivity profiles.